Financials
- Market Capitalization 2.19 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
7.71
市销率
7.82
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1927 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 21.59 USD | +10.95% | +11.35% | +39.92% | +17.98% | 2.28 B USD | ||
| 1937 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.50 USD | -0.96% | -2.94% | +10.71% | +139.47% | 2.22 B USD | ||
| 1953 | NBTX Nanobiotix S.A. - ADSs | 45.16 USD | +1.48% | +2.78% | +20.36% | +385.59% | 2.19 B USD | ||
| 1958 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 8.37 USD | -5.96% | +1.09% | +22.55% | +251.68% | 2.17 B USD |